@Tim_0_Thy @EFhutton420 @SeanFromFinance @jondavid
I emailed them about the manufacture, and here's their reply from 6/24/20:
...thank you for your email. The Company has agreements with Cosma S.p.A. to supply metoclopramide for the manufacture of Gimoti, and with Thermo Fisher Scientific Inc., who acquired Patheon UK Limited, for product development and manufacturing of Gimoti.
The Company currently utilizes third-party consultants, which it engages on an as-needed, hourly basis, to manage product development and manufacturing contractors.
Also, the board is obligated to review any reasonable buy-out offer they receive.